Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics

Authors: Ali H Zarzour, Mohie Selim, Alaa A Abd-Elsayed, Diaa A Hameed, Mohammad A AbdelAziz

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

In Egypt, where bilharziasis is endemic, bladder cancer is the commonest cancer in males and the 2nd in females; squamous cell carcinoma (SCC) is the commonest type found, with a peculiar mode of presentation. The aim of this study is to identify and rank the risk factors of muscle invasive bladder cancer (MIBC) in Upper Egypt and describe its specific criteria of presentation and histopathology.

Methods

This is an analytical, hospital based, case controlled study conducted in south Egypt cancer institute through comparing MIBC cases (n = 130) with age, sex and residence matched controls (n = 260) for the presence of risk factors of MIBC. Data was collected by personal interview using a well designed questionnaire. Patients' records were reviewed for histopathology and Radiologic findings.

Results

The risk factors of MIBC were positive family history [Adjusted odds ratio (AOR) = 7.7], exposure to pesticides [AOR = 6.2], bladder stones [AOR = 5], consanguinity [AOR = 3.9], recurrent cystitis [AOR = 3.1], bilharziasis [odds ratio (OR) = 5.8] and smoking [OR = 5.3]. SCC represented 67.6% of cases with burning micturition being the presenting symptom in 73.8%.

Conclusion

MIBC in Upper Egypt is usually of the SCC type (although its percentage is decreasing), occurs at a younger age and presents with burning micturition rather than hematuria. Unlike the common belief, positive family history, parents' consanguinity, exposure to pesticides and chronic cystitis seem to play now more important roles than bilharziasis and smoking in the development of this disease in this area.
Appendix
Available only for authorised users
Literature
2.
go back to reference Public health impact of schistosomiasis: disease and mortality. WHO Expert Committee on the Control of Schistosomiasis. Bull World Health Organ. 1993, 71 (6): 657-662. Public health impact of schistosomiasis: disease and mortality. WHO Expert Committee on the Control of Schistosomiasis. Bull World Health Organ. 1993, 71 (6): 657-662.
3.
go back to reference Khaled HM: Systemic management of bladder cancer in Egypt: revisited; as well as: Expert Opin Investig Drugs. J Egypt Natl Canc Inst. 2005, 17 (3): 127-31.PubMed Khaled HM: Systemic management of bladder cancer in Egypt: revisited; as well as: Expert Opin Investig Drugs. J Egypt Natl Canc Inst. 2005, 17 (3): 127-31.PubMed
4.
go back to reference Amal SI, El-Sebai I: Epidemiology of bladder cancer and ligand binding. 1983, Cancer bladder, Inc Florida Press, 1: 28-32. Amal SI, El-Sebai I: Epidemiology of bladder cancer and ligand binding. 1983, Cancer bladder, Inc Florida Press, 1: 28-32.
6.
go back to reference Mensing TT, Speijers GJ, Meulenbelt J: Health implications of exposure to environmental nitrogenous compounds. Toxicol Rev. 2003, 22 (1): 41-51. 10.2165/00139709-200322010-00005.CrossRef Mensing TT, Speijers GJ, Meulenbelt J: Health implications of exposure to environmental nitrogenous compounds. Toxicol Rev. 2003, 22 (1): 41-51. 10.2165/00139709-200322010-00005.CrossRef
7.
go back to reference Webster LR, McKenzie GH, Moriarty HT: Organophosphate based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet. 2002, 133 (2): 112-117. 10.1016/S0165-4608(01)00576-3.CrossRefPubMed Webster LR, McKenzie GH, Moriarty HT: Organophosphate based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet. 2002, 133 (2): 112-117. 10.1016/S0165-4608(01)00576-3.CrossRefPubMed
8.
go back to reference Wu Xifeng, Jie Lin H, Grossman Barton, Huang Maosheng, Gu Jian, Carol J, Etzel Amos CI, Dinney CP, Spitz MR: Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals. Journal of Clinical Oncology. 2007, 25 (31): 4974-4981. 10.1200/JCO.2007.10.7557.CrossRefPubMed Wu Xifeng, Jie Lin H, Grossman Barton, Huang Maosheng, Gu Jian, Carol J, Etzel Amos CI, Dinney CP, Spitz MR: Projecting Individualized Probabilities of Developing Bladder Cancer in White Individuals. Journal of Clinical Oncology. 2007, 25 (31): 4974-4981. 10.1200/JCO.2007.10.7557.CrossRefPubMed
9.
go back to reference LaRue H, Simoneau M, Fradet Y: Human papilloma virus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res. 1995, 1: 435-438.PubMed LaRue H, Simoneau M, Fradet Y: Human papilloma virus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res. 1995, 1: 435-438.PubMed
10.
go back to reference El-Bolkainy MN, Akram Nouh M, El-Bolkainy T: Cancer of urinary tract. Topographic Pathology of Cancer. 2005, 7: 57-64. 3 El-Bolkainy MN, Akram Nouh M, El-Bolkainy T: Cancer of urinary tract. Topographic Pathology of Cancer. 2005, 7: 57-64. 3
11.
go back to reference Lynch CF, Cohen MB: Urinary system. Cancer. 1995, 1;75 (1 Suppl): 316-329. 10.1002/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T.CrossRef Lynch CF, Cohen MB: Urinary system. Cancer. 1995, 1;75 (1 Suppl): 316-329. 10.1002/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T.CrossRef
12.
go back to reference El-Mawla NG, EL-Bolkainy MN, Khaled HM: Bladder cancer in Africa: update. Semin Oncol. 2001, 28: 174-178. 10.1053/sonc.2001.21961.CrossRefPubMed El-Mawla NG, EL-Bolkainy MN, Khaled HM: Bladder cancer in Africa: update. Semin Oncol. 2001, 28: 174-178. 10.1053/sonc.2001.21961.CrossRefPubMed
13.
go back to reference Lynch HT, Ens JA, Lynch JF: The Lynch syndrome II and urological malignancies. J Urol. 1990, 143: 24-27.PubMed Lynch HT, Ens JA, Lynch JF: The Lynch syndrome II and urological malignancies. J Urol. 1990, 143: 24-27.PubMed
14.
go back to reference Mostafa MH, Sheweita SA, O'Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999, 12: 97-111.PubMedPubMedCentral Mostafa MH, Sheweita SA, O'Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999, 12: 97-111.PubMedPubMedCentral
15.
go back to reference Cheever AW: Schistosomiasis and neoplasia. J Natl Cancer Inst. 1978, 61: 13-18.PubMed Cheever AW: Schistosomiasis and neoplasia. J Natl Cancer Inst. 1978, 61: 13-18.PubMed
16.
go back to reference Badawi AF, Mostafa MH, Probert A, O'Connor PJ: Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev. 1995, 4: 45-59. 10.1097/00008469-199502000-00004.CrossRefPubMed Badawi AF, Mostafa MH, Probert A, O'Connor PJ: Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev. 1995, 4: 45-59. 10.1097/00008469-199502000-00004.CrossRefPubMed
18.
go back to reference Merzabani MM, El-Aaser AA: Etiological factors of bilharzial bladder cancer in Egypt: nitrosamines and their precursors in urine. Eur J Cancer. 1979, 15: 287-291.CrossRefPubMed Merzabani MM, El-Aaser AA: Etiological factors of bilharzial bladder cancer in Egypt: nitrosamines and their precursors in urine. Eur J Cancer. 1979, 15: 287-291.CrossRefPubMed
19.
go back to reference Burch JD, Rohan TE, Howe GR, Risch HA, Hill GP, Steel R, Miller AB: Risk of bladder cancer by source and type of tobacco exposure: A case-control study. Int J Cancer. 1989, 44: 622-626. 10.1002/ijc.2910440411.CrossRefPubMed Burch JD, Rohan TE, Howe GR, Risch HA, Hill GP, Steel R, Miller AB: Risk of bladder cancer by source and type of tobacco exposure: A case-control study. Int J Cancer. 1989, 44: 622-626. 10.1002/ijc.2910440411.CrossRefPubMed
20.
go back to reference Radosavljevic V, Ilic M, Jankovic S: Epidemiology and risk factors for the onset of urinary bladder cancer. Vojnosanit Pregl. 2003, 60: 195-201.CrossRefPubMed Radosavljevic V, Ilic M, Jankovic S: Epidemiology and risk factors for the onset of urinary bladder cancer. Vojnosanit Pregl. 2003, 60: 195-201.CrossRefPubMed
21.
go back to reference Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML: The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control. 2008, 19 (4): 421-9. 10.1007/s10552-007-9104-7.CrossRefPubMedPubMedCentral Felix AS, Soliman AS, Khaled H, Zaghloul MS, Banerjee M, El-Baradie M, El-Kalawy M, Abd-Elsayed AA, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Wilson ML: The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control. 2008, 19 (4): 421-9. 10.1007/s10552-007-9104-7.CrossRefPubMedPubMedCentral
22.
go back to reference El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH: The impact of schistosomiasis on the pathology of bladder carcinoma. Int J Cancer. 1981, 48: 2643-2651. El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH: The impact of schistosomiasis on the pathology of bladder carcinoma. Int J Cancer. 1981, 48: 2643-2651.
23.
go back to reference Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, El-Baz MA: Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol. 2008, 180 (1): 121-7. 10.1016/j.juro.2008.03.024.CrossRefPubMed Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, El-Baz MA: Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol. 2008, 180 (1): 121-7. 10.1016/j.juro.2008.03.024.CrossRefPubMed
24.
go back to reference Herr HW, Shipley WU, Bajorin DF: Cancer of the bladder. Principles and practice of oncology. 2001, Philadelphia, Williams and Wilkins press, 1396-1401. 6 Herr HW, Shipley WU, Bajorin DF: Cancer of the bladder. Principles and practice of oncology. 2001, Philadelphia, Williams and Wilkins press, 1396-1401. 6
25.
go back to reference El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A: Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int J Clin Oncol. 2005, 10: 20-25. 10.1007/s10147-004-0457-6.CrossRefPubMed El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A: Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int J Clin Oncol. 2005, 10: 20-25. 10.1007/s10147-004-0457-6.CrossRefPubMed
26.
go back to reference Ghoneim MA, El-Makresh MM, El-Baz MA, El-Attar IA, Ashamallah A: Radical cystectomy for carcinoma of the bladder. Critical evaluation of the results in 1026 cases. J Urol. 1997, 158: 393-399. 10.1016/S0022-5347(01)64487-2.CrossRefPubMed Ghoneim MA, El-Makresh MM, El-Baz MA, El-Attar IA, Ashamallah A: Radical cystectomy for carcinoma of the bladder. Critical evaluation of the results in 1026 cases. J Urol. 1997, 158: 393-399. 10.1016/S0022-5347(01)64487-2.CrossRefPubMed
Metadata
Title
Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics
Authors
Ali H Zarzour
Mohie Selim
Alaa A Abd-Elsayed
Diaa A Hameed
Mohammad A AbdelAziz
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-250

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine